Fayad Fouad, Lefevre-Colau Marie-Martine, Rannou François, Quintero Nathaly, Nys Alain, Macé Yann, Poiraudeau Serge, Drapé Jean Luc, Revel Michel
Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, Hôpital Cochin (AP-HP), Université Paris 5, 75014 Paris, France.
Eur Spine J. 2007 Jul;16(7):925-31. doi: 10.1007/s00586-006-0301-y. Epub 2007 Jan 10.
The purpose of this study was to analyze the association between the severity of inflammatory endplate changes (Modic) on MRI and the clinical response to intradiscal injection of corticosteroids (IDIC) in chronic low back pain (LBP). A total of 74 patients with LBP and inflammatory Modic changes who showed no response to 3-month conservative treatment received lumbar IDIC. Two spine specialists and a radiologist assessed independently the endplate marrow changes of the injected discs. We classified patients with a pure edema endplate changes on MRI as Modic type I (n = 37); those with a mixture of Modic type I and type II changes but predominantly edema changes as Modic I-2 (n = 25) and those with predominantly fatty changes as Modic II-1 (n = 12). The primary outcome was the change in LBP intensity between baseline and 1 month after IDIC, as measured on a visual analog scale (range 0-100 mm). At 1 month, reduction in pain score was significantly higher in the Modic I and Modic I-2 groups than in the Modic II-1 group (30.2 +/- 26.6 and 29.4 +/- 21.5 vs 5.3 +/- 25.5; P = 0.009 and P = 0.017, respectively). At 3 and 6 months, IDIC tended to be more effective in the Modic I and Modic I-2 groups but not significantly. No complications such as infection or hematoma were reported. IDIC could be a short-term efficient treatment for patients with chronic LBP and predominantly inflammatory endplate changes when conservative treatments have failed.
本研究的目的是分析慢性下腰痛(LBP)患者MRI上炎性终板改变(Modic)的严重程度与椎间盘内注射皮质类固醇(IDIC)临床反应之间的关联。共有74例LBP且有炎性Modic改变、对3个月保守治疗无反应的患者接受了腰椎IDIC治疗。两名脊柱专家和一名放射科医生独立评估注射椎间盘的终板骨髓变化。我们将MRI上单纯水肿性终板改变的患者分类为Modic I型(n = 37);那些有Modic I型和II型改变混合但以水肿改变为主的患者为Modic I-2型(n = 25),以脂肪改变为主的患者为Modic II-1型(n = 12)。主要结局是IDIC治疗后1个月与基线相比LBP强度的变化,采用视觉模拟量表(范围0 - 百毫米)进行测量。在1个月时,Modic I型和Modic I-2型组的疼痛评分降低显著高于Modic II-1型组(分别为30.2±26.6和29.4±21.5 vs 5.3±25.5;P = 0.009和P = 0.017)。在3个月和6个月时,IDIC在Modic I型和Modic I-2型组中往往更有效,但差异不显著。未报告感染或血肿等并发症。当保守治疗失败时,IDIC可能是慢性LBP且主要为炎性终板改变患者的短期有效治疗方法。